Navigation Links
Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes

SAN FRANCISCO, Calif., March 26, 2007 /PRNewswire/ -- DiObex, Inc., a privately- held biopharmaceutical company focused on the development of therapeutics to treat metabolic diseases, today announced positive phase 2a results for DIO- 902, a novel Cortisol Synthesis Inhibitor.

In a recently completed multi-center, randomized, placebo-controlled trial, patients with type 2 diabetes were treated for two weeks to evaluate the safety, pharmacokinetics and activity of three dose levels of DIO-902. After two weeks of treatment, patients at all dose levels of DIO-902 showed significant reductions in total and LDL-cholesterol as well as trends toward an improvement in glycemic control as measured by HbA1c, fructosamine and fasting blood glucose. Mean levels of C-reactive protein, an inflammatory marker, were also significantly reduced. In contrast, metabolic control in patients in the placebo group remained stable or deteriorated slightly. These data lend support to the concept that abnormalities in cortisol activity may play an important role in the causation of type 2 diabetes and metabolic syndrome, a cluster of co-morbidities commonly associated with type 2 diabetes and insulin resistance. In the growing number of patients with type 2 diabetes and metabolic syndrome, co-morbidities such as hypertension and abnormal lipoprotein levels dramatically increase the risk of cardiovascular disease.

DIO-902 is one of two enantiomers contained within racemic ketoconazole, a marketed drug. Results of a separate drug-interaction study, conducted in normal healthy volunteers, in which Lipitor(R) (atorvastatin) was co- administered with DIO-902, support the co-administration of DIO-902 with the most commonly used doses of atorvastatin. This study also provided clinical evidence of a significant differential effect of DIO-902 and racemic ketoconazole on the metabolism of atorvastatin, thereby reducing the potential
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the leading ... recognized as a winner of Red Herring,s Top ... Top 100 North America award in 2013, marking its ... landscape. Red Herring,s Top 100 Global list ... new companies and entrepreneurs. Red Herring editors were among ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
(Date:11/26/2014)... Nov. 25, 2014  Array BioPharma Inc. ... that its Chief Executive Officer, Ron ... upcoming conferences.  The public is welcome to ... the Array BioPharma website:  www.arraybiopharma.com .Event: Piper ... p.m.  Eastern Time Location: Palace Hotel, New ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Nanomix Receives ISO 13485:2003 Certification 2
... YORK, May 21, 2012  Delcath Systems, Inc. (Nasdaq: ... to shareholders at the Company,s annual stockholder meeting on May ... in New York City. The presentation will commence at approximately ... webcast and view slides of the presentation during or after ...
... InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the ... services, today announced that it received a letter from ... of the "record date" for the 2012 Annual Stockholders, ... record date for the Company,s 2012 Annual Meeting, meaning ...
Cached Medicine Technology:Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders 2Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders 3InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2
(Date:11/26/2014)... OR (PRWEB) November 26, 2014 The ... fresh water shortages, is moving forward with a plan ... drinking water.* Radio host Sharon Kleyne supports the San ... “Total Water Management” (TWM). According to Kleyne, by recycling ... constantly import new water could be greatly reduced. (Spagat, ...
(Date:11/26/2014)... November 26, 2014 With a redesign ... Dr. Steven Meier has enhanced the user experience ... and prospective patients an online destination for orthopedic and ... to present the new and improved version of the ... it easier than ever for current and prospective patients ...
(Date:11/26/2014)... November 26, 2014 Senior Planning Services, ... SeniorNet, a nonprofit organization providing the adult demographic ... to help seniors navigate the rough seas of applying ... educating seniors on the topic of Medicaid eligibility and ... complicated process of applying for this coverage. , ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Anthropologists ... effectiveness in containing and stopping Ebola, improve international ... in healthcare systems in West Africa. , ... to Stop Ebola: Anthropologists Offer Insights,” will be ... the American Anthropological Association (AAA), Fri., Dec. 5, ...
(Date:11/26/2014)... November 26, 2014 Bunion Bootie, the ... prices in an early celebration of the early holiday ... being offered at the promotional price of $29.95 each ... in addition to any automatic discounts applied when buying ... Bootie website for complete details. It’s simple: purchasing ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... Scripps ... from the American Nurses Credentialing Center (ANCC). , ... La Jolla, CA (Vocus) June 16, 2010 -- ... excellence from the American Nurses Credentialing Center (ANCC). , , , , ,The new ...
... a majority of cases, due to late diagnosis of the ... Biodesign Institute at Arizona State University, along with Arturo Ramirez ... Center in Seattle, used a novel method for identifying ... appear. The work, which appeared recently in the ...
... ... for everyone: Protect your PC and files at home with free ... of portable storage devices (USB Flash Drives, external hard drives, digital ... and MACs,• Free data loss and theft protection for home and individual ...
... (ASTRO) continued to advance its Target Safely initiative by ... meeting on Device Improvements to Reduce the Number of ... June 9 and 10. ASTRO commends the FDA on ... develop data, which will help inform the FDA,s actions ...
... drug abuse, study finds , WEDNESDAY, June 16 (HealthDay News) ... abuse treatment have nearly doubled between 1992 and 2008, a ... and/or marijuana abuse among men and women aged 50 and ... 12 percent by 2008, according to researchers from the U.S. ...
... in French . , Montreal, June 16, ... Research in Immunology and Cancer (IRIC) of the Universit de ... three cancer-causing genes in acute lymphoblastic leukemia. Published in the ... on the complex interaction between the genes and their contributions ...
Cached Medicine News:Health News:Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation 2Health News:Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation 3Health News:Blood relations 2Health News:Blood relations 3Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 2Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 3Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 4Health News:'Graying' of Drug Users at U.S. Treatment Centers 2Health News:Montreal researchers shed light on common juvenile cancer 2
... new age of non-surgical facial contouring materials. ... long-term results for various applications with exceptional ... superior versatility for a wide variety of ... saves time and money for both you ...
... Response is a whole blood ... be used at the point-of-care. ... screen and data management features, ... options. QC and operator lockout ...
... a revolutionary scientific breakthrough for controlling unsightly ... Cream permits you to spot reduce in ... can rid yourself of those unwanted lumps ... to your thigh, waist, tummy, or chin ...
... has been developed specifically to fight Cellulite ... and hips. It does this by stimulating ... fluids in your body, which then are ... daily, for about 15 minutes each treatment. ...
Medicine Products: